| | | | |

Physicians and patients weigh in on latest poorly designed study that raises the question, “Why?”, and, “Who is driving this spin?”

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease Comment “Persister research needs to account for morphological variability of Lyme The patient population studied was already a group that had shown persistence of disease. These would be “treatment failures” and more difficult cases. Even in this difficult population every group who received 2…

| | | | |

Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime

Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA https://dx.doi.org/10.3389/fmicb.2016.00062  10 February 2016 Lyme disease, caused by Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. While the majority of Lyme disease patients can resolve their symptoms if treated promptly, 10–20% of…